The origins of evolutionary novelty are notoriously difficult to predict in advance or even to pinpoint in retrospect. Qualitatively new traits can arise due to complex mutational events, such as regulatory changes (1), or exaptation of genes coding for existing functions (2) . This often involves multiple mutations that are all required to produce a novel function, making evolutionary innovation historically contingent on the chance order of random mutational events (3) . Lenski and colleagues recently discovered a striking example of this process in their long-term evolution experiment (LTEE) in Escherichia coli: after more than 31,000 generations of evolution, 1 of 12 replicate lines evolved the ability to metabolize citrate under oxic conditions (4) . Inability to grow aerobically on citrate is often used to define E. coli as a species (5), so the spontaneous appearance of this citratemetabolizing phenotype offers an unprecedented opportunity to study the mechanisms underlying a major evolutionary innovation. The work by Quandt et al. (6) in PNAS sheds new light on the genetic basis of this novel trait.
Previous studies have shown that the ability to robustly metabolize citrate under aerobic conditions evolved in the LTEE via at least three distinct mutational events. First, an as-yet undetermined potentiating mutation or mutations created a genetic background in which the citrate-metabolizing phenotype was possible (4 (Fig. 1A) .
This minimal set of mutations turned out to be surprisingly small. As expected, Quandt et al. found the actualizing rnk-citG mutation, along with a known refinement mutation, dsbG-insA-9. The only other mutation on the list was dctA*, a mutation in the promoter region of dctA that appeared in the LTEE after the rnk-citG mutation. No potentiating mutations were found. To exclude the possibility that some mutations were missed at the sequencing stage, Quandt et al. (6) show that the combination of just two mutations, rnkcitG and dctA*, is indeed necessary and sufficient to convert the ancestral Cit -strain into a Cit ++ strain. This contradicts the all-or-none epistasis hypothesis and suggests a different scenario for the evolution of the Cit ++ phenotype. Even though potentiating mutation(s) One or more mutations (yellow) that potentiated the evolution of citrate utilization arose by generation 20,000 of the LTEE. This was followed by the rnk-citG actualizing mutation (orange) that conferred a weak Cit were required for the actualizing rnk-citG mutation to become beneficial and were therefore essential to the original evolution of the citrate metabolism, they are rendered obsolete by the subsequent dctA* refinement mutation. The physiological effect of the dctA* mutation suggests the mechanistic basis for this interesting type of epistasis. Quandt et al. (6) find that the dctA* mutation increases the expression of DctA, a C 4 -dicarboxylate transporter (8) . They hypothesize that the rnk-citG actualizing mutation is not initially beneficial in the LTEE ancestor because intracellular concentrations of succinate and other C 4 -dicarboxylates are too low to power citrate import via the CitT antiporter. The unknown potentiation mutation(s) somehow increase the intracellular supply of C 4 -dicarboxylates, enabling the rnk-citG mutation to power citrate import and hence confer the weak Cit + phenotype. The dctA* refinement mutation then allows for the recovery of exported C 4 -dicarboxylates, enabling much more efficient import of citrate by the CitT antiporter. This makes the original potentiating mutation(s) superfluous for the Cit ++ phenotype. However, because succinate and other C 4 -dicarboxylates are otherwise rare in the media, the dctA* mutation is unlikely to be beneficial in the absence of rnk-citG.
These results highlight the importance of historical contingency in the evolution of this metabolic innovation. Why did the E. coli of Lenski and colleagues not take the most direct evolutionary path from Cit − to Cit ++ via just two mutations, dctA* and rnk-citG?
The answer probably lies in the shape of the "fitness landscape" on which these populations evolve (Fig. 1B) . Only the rnk-citG and dctA* mutations are required for the Cit ++ phenotype, but because both are likely to be neutral or deleterious on their
The dynamics of the evolutionary process, which proceeds by tinkering rather than by design, are key to understanding the mechanisms underlying novel phenotypes.
own, evolution cannot easily find this solution. Instead, the potentiating mutation(s) provide a way around this dynamical barrier. This is similar in spirit to the conclusions of another recent experimental study, which found that adaptation of budding yeast to high temperature proceeded initially by wholechromosome duplications that were later replaced by more refined adaptive solutions (9) . In both of these systems, the dynamics of the evolutionary process, which proceeds by tinkering rather than by design, are key to understanding the mechanisms underlying novel phenotypes.
It is interesting to note that a purely retrospective analysis could easily have concluded that only the rnk-citG and dctA* mutations were involved in the evolution of the Cit ++ phenotype. This would imply an adaptive trajectory in which evolution crossed a fitness valley or plateau. However, the earlier evidence (4, 7) for the existence of potentiating mutation(s) shows that this is not necessarily the case. This argues for a degree of caution in interpreting other retrospective analyses of epistasis among mutations that underlie the evolution of any given trait. Later refining mutations can mask the effects of earlier steps, making them difficult to detect and leading to a qualitatively incorrect picture of the evolutionary history. Even in this system, where the existence of potentiating mutation(s) is already suspected, the masking effect of the dctA* mutation makes them difficult to find. Thus far, their identity remains an intriguing mystery.
